Literature DB >> 12112652

Familial conformational diseases and dementias.

Damian C Crowther1.   

Abstract

Familial conformational diseases occur when a mutation alters the conformation of a protein resulting in abnormal intermolecular interactions, protein aggregation, and consequent tissue damage. The molecular mechanisms of conformational disease are best understood for the serine protease inhibitor (serpin) superfamily of proteins. The serpinopathies include alpha(1)-antitrypsin (SERPINA1) deficiency and the newly characterized familial encephalopathy with neuroserpin inclusion bodies (FENIB) resulting from mutations in the neuroserpin (SERPINI1) gene. This review discusses how insights gained from the study of the serpins may be used to guide our research into other common diseases such as Alzheimer disease, Huntington disease, and Parkinson disease. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112652     DOI: 10.1002/humu.10100

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

1.  Liquid-liquid phase separation in hemoglobins: distinct aggregation mechanisms of the beta6 mutants.

Authors:  Qiuying Chen; Peter G Vekilov; Ronald L Nagel; Rhoda Elison Hirsch
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

Review 2.  Protein misfolding, aggregation, and degradation in disease.

Authors:  Niels Gregersen; Lars Bolund; Peter Bross
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

3.  Chaperone-like effect of the linker on the isolated C-terminal domain of rabbit muscle creatine kinase.

Authors:  Zhe Chen; Xiang-Jun Chen; Mengdie Xia; Hua-Wei He; Sha Wang; Huihui Liu; Haipeng Gong; Yong-Bin Yan
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

4.  Amyloid-β depresses excitatory cholinergic synaptic transmission in Drosophila.

Authors:  Liqun Fang; Jingjing Duan; Dongzhi Ran; Zihao Fan; Ying Yan; Naya Huang; Huaiyu Gu; Yulan Zhu
Journal:  Neurosci Bull       Date:  2012-10-03       Impact factor: 5.203

Review 5.  The role of amyloidogenic protein oligomerization in neurodegenerative disease.

Authors:  Gregor P Lotz; Justin Legleiter
Journal:  J Mol Med (Berl)       Date:  2013-03-27       Impact factor: 4.599

6.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

7.  Common variation in genes related to innate immunity and risk of adult glioma.

Authors:  Preetha Rajaraman; Alina V Brenner; Mary Ann Butler; Sophia S Wang; Ruth M Pfeiffer; Avima M Ruder; Martha S Linet; Meredith Yeager; Zhaoming Wang; Nick Orr; Howard A Fine; Deukwoo Kwon; Gilles Thomas; Nathaniel Rothman; Peter D Inskip; Stephen J Chanock
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

Review 8.  Alpha-1-antitrypsin deficiency: current concepts.

Authors:  Alan T Mulgrew; Clifford C Taggart; N Gerry McElvaney
Journal:  Lung       Date:  2007-06-12       Impact factor: 2.584

9.  Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.

Authors:  Sarah Jesse; Stefan Lehnert; Olaf Jahn; Lucilla Parnetti; Hilkka Soininen; Sanna-Kaisa Herukka; Petra Steinacker; Saskia Tawfik; Hayrettin Tumani; Christine A F von Arnim; Manuela Neumann; Hans A Kretzschmar; Hasan Kulaksiz; Martin Lenter; Jens Wiltfang; Boris Ferger; Bastian Hengerer; Markus Otto
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

10.  Effect of SNPs on creatine kinase structure and function: identifying potential molecular mechanisms for possible creatine kinase deficiency diseases.

Authors:  Chang Li; Qian Zhang; Wei-Jiang Hu; Hang Mu; Zong Lin; Long Ma; Yong-Doo Park; Hai-Meng Zhou
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.